GensKey Medicine

GensKey, as a leading enterprise in the field of high-throughput genetic testing for infectious pathogens, has established medical testing laboratories in Beijing, Shanghai, Tianjin, Guangzhou, and Wuhan. Currently, GensKey has become the gene testing company with the most medical testing laboratories in China and the fastest delivery time for infectious disease testing. At the same time, GensKey is actively promoting the integration of its "Golden Insight Original" pathogen metagenomic testing project into hospitals, providing comprehensive solutions for infectious disease gene testing to large tertiary hospitals in more than ten cities, including Shenzhen, Chengdu, Zhengzhou, Xi'an, and Nanchang. By collaborating with medical institutions to achieve localized delivery, GensKey has enhanced the diagnostic capabilities and hospital infection monitoring capacities of these hospitals.GensKey places great emphasis on combining product development with clinical practice and has established deep cooperative relationships with top medical institutions such as China-Japan Friendship Hospital, Peking University People's Hospital, West China Hospital of Sichuan University, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Lu Daopei Medical Group. It conducts multi-center clinical research in disciplines such as respiratory, hematology, and infectious diseases, customizes pathogen metagenomic experimental workflows and algorithms in depth, and launches differentiated pathogenic gene testing products to improve detection sensitivity and specificity. Based on nanopore third-generation sequencing technology, GensKey also introduces rapid testing and drug-resistance molecular diagnostic products, striving to precisely address challenges in clinical infections and quality control in pharmaceuticals and biologics.